GALLSTONES IN PATIENTS WITH INHERITED HEMOLYTIC DISEASES
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2015, Vol 7, Issue 7
Abstract
The purpose is to provide an overview on the incidence of gallstone disease in patients with various types of inherited (chronic) hemolytic diseases at risk of cholelithiasis/choledocholithiasis with particular emphasis on its pathogenesis, genetic, risk factors and management. A detailed electronic literature search to determine the source of materials for this review article was done. The reported incidences of gallstones and choledocholithiasis vary according to the different types of inherited hemolytic diseases and the ethnicity of the studied populations. To date, no review article summarises the incidences of cholelithiasis in patients with various inherited haemolytic diseases was published. Regular ultrasound examination for the presence of gallstones recommended in patients with inherited haemolytic anaemias, particularly those with additional risk factors recommended. Further studies for evaluating the reasons for the higher incidence of cholelithiasis in thalassemia major and sickle cell anemia compared to hereditary spherocytosis; the effect of co inheritance of alpha thalassaemia on decreasing bilirubin level in patients with sickle cell disease and beta thalassaemia; the effect of the co inheritance of UGT1A1 and ABCG8 gene mutation on the incidence of gallstones in other blood diseases such as Hb-H disease, autoimmune haemolytic anaemias, congenital dyserythropoietic anaemia, hereditary elliptocytosis, Southeast Asian Ovalocytosis, glucose-6-phosphate and pyruvate kinase deficiency are recommended. Evaluation of the potential role of the solubility of the mutant proteins and haemoglobin subunit in the red blood cells as an additional mechanism for the development of gallstones in patients with inherited haemolytic anaemias recommended.
Authors and Affiliations
Uday Y. H. Abdullah, Haitham M. Jassim, Atif A. Baig, Rana M. Khorsheed, Ali M. H. Al-khayat, Ahmad F. B. Sulong, Nagham F. Abed, Wisam A. Yassin
Keywords
Related Articles
- EP ID EP578509
- DOI -
- Views 53
- Downloads 0
EFFECT OF CRUDE SULPHATED POLYSACCHARIDE FROM MARINE BROWN ALGAE IN TPA INDUCED INFLAMMATION ON POLY MORPHONUCLEAR LEUKOCYTES
Objective: The present study aims to evaluate the anti-inflammatory activity of crude sulphated polysaccharide from marine brown algae sargassum ilicifoliumMethods: The present study involves the investigation of crude s...
BIO-PROSPECTING THE IN-VITRO ANTIOXIDANT AND ANTI-CANCER ACTIVITIES OF SILVER NANOPARTICLES SYNTHESIZED FROM THE LEAVES OF SYZYGIUM SAMARANGENSE
Objective: Green nanotechnology involves the tailoring of nanoparticles through a reliable and eco-friendly process making it suitable for a desired application. The current study is focussed on the biosynthesis of silve...
COMPUTATIONAL INTERACTION OF ENTOMOPATHOGENIC FUNGAL SECONDARY METABOLITES WITH PROTEINS INVOLVED IN HUMAN XENOBIOTIC DETOXIFICATION
Objective: Entomopathogenic fungi are rich source of secondary metabolites which posses both pharmacological and insecticidal activity. It is essential to assess metabolite toxicity of chemically diverse toxic metabolite...
A CASE REPORT: DRUG INTERACTION BETWEEN LINEZOLID AND DOPAMINE
Linezolid is a weak, non-selective inhibitor of monoamine oxidase (MAO). It can inhibit the breakdown of the tyramine by MAO in the gut and can also potentiate the effect of tyramine at nerve endings, thereby causing an...
EFFECT OF STANDARDIZED EURYCOMA LONGIFOLIA EXTRACT ON PHASE I ROSIGLITAZONE METABOLISM IN THE OLD NORMAL MALE RAT HEPATOCYTES: A MECHANISM STUDY
Objective: The aim of present study was to evaluate the possible mechanism of E. longifolia extract in affecting phase I Rosiglitazone metabolism in the old normal male rat hepatocytes. Methods: Experiment was performed...